Article
Magnesium Sulphate in Neonatal Hypoxic-Ischemic Encephalopathy: Bridging the Gap Between Molecular Neuroprotection and Clinical Outcomes
2026-07-21
Abstract excerpt
Neonatal hypoxic-ischemic encephalopathy (HIE) remains one of the leading causes of neonatal mortality and long-term neurodevelopmental disability despite therapeutic hypothermia, which provides only partial neuroprotection. Among adjunctive therapies, magnesium sulphate (MgSO4) has emerged as one of the most biologically plausible neuroprotective agents because of its ability to modulate glutamate-mediated excito...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- eec27536-5e06-5753-ba18-472d1ae87dc0
- DOI
- 10.20944/preprints202607.1491.v1
